Osborne Partners Capital Management, LLC Pfizer Inc Transaction History

Osborne Partners Capital Management, LLC

$1.65 Billion
Q2 2024

A detailed history of Osborne Partners Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Osborne Partners Capital Management, LLC holds 190,179 shares of PFE stock, worth $5.66 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

190,179

Previous 180,379 5.43%

Holding current value

$5.66 Million

Previous $5.01 Million 6.31%

% of portfolio

0.32%

Previous 0.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $247,548 - $290,080	9,800 Added 5.43%	190,179 $5.32 Million
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $61,488 - $70,608	-2,375 Reduced 1.3%	180,379 $5.01 Million
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $1,254 - $1,629	48 Added 0.03%	182,754 $5.26 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $128,039 - $149,664	-3,990 Reduced 2.14%	182,706 $6.06 Million
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $7,296 - $8,441	-202 Reduced 0.11%	186,696 $6.85 Million
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $50,497 - $65,740	1,282 Added 0.69%	186,898 $7.63 Million
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $27,179 - $35,479	651 Added 0.35%	185,616 $0
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $2.21 Million - $2.7 Million	-50,493 Reduced 21.44%	184,965 $8.09 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $9.19 Million - $10.9 Million	197,584 Added 521.69%	235,458 $12.3 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $74,618 - $92,461	-1,631 Reduced 4.13%	37,874 $1.96 Million
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $136,232 - $201,941	-3,297 Reduced 7.7%	39,505 $2.33 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $10,519 - $13,512	-268 Reduced 0.62%	42,802 $1.84 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $94,443 - $106,988	-2,630 Reduced 5.75%	43,070 $1.69 Million
Q1 2021 Aug 09, 2021	SELL	$33.49 - $37.77 $8.16 Million - $9.2 Million	-243,574 Reduced 84.2%	45,700 $1.66 Million
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $94,609 - $106,700	-2,825 Reduced 0.97%	289,274 $10.5 Million
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $8.06 Million - $10.2 Million	240,690 Added 468.19%	292,099 $10.8 Million
Q3 2020 Oct 28, 2020	SELL	$31.75 - $37.25 $17,462 - $20,487	-550 Reduced 1.06%	51,409 $1.89 Million
Q2 2020 Jul 23, 2020	SELL	$30.12 - $36.54 $13,554 - $16,443	-450 Reduced 0.86%	51,959 $1.7 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $31,165 - $44,528	-1,153 Reduced 2.15%	52,409 $1.71 Million
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $16,460 - $18,680	-500 Reduced 0.92%	53,562 $2.1 Million
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $2,339 - $3,033	-72 Reduced 0.13%	54,062 $1.94 Million
Q2 2019 Jul 18, 2019	SELL	$36.98 - $41.52 $55,469 - $62,280	-1,500 Reduced 2.7%	54,134 $2.35 Million
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $9.19 Million - $10.1 Million	-245,151 Reduced 81.5%	55,634 $2.36 Million
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $46,164 - $52,632	-1,200 Reduced 0.4%	300,785 $13.1 Million
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $2,206 - $2,675	64 Added 0.02%	301,985 $13.3 Million
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $56,065 - $59,771	1,700 Added 0.57%	301,921 $11 Million
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $47,290 - $54,863	-1,482 Reduced 0.49%	300,221 $10.7 Million
Q4 2017 Jan 25, 2018	BUY	$33.26 - $35.29 $7,782 - $8,257	234 Added 0.08%	301,703 $10.9 Million
Q3 2017 Oct 19, 2017	BUY	$31.0 - $34.15 $9.35 Million - $10.3 Million	301,469	301,469 $10.8 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.

Account

Osborne Partners Capital Management, LLC Pfizer Inc Transaction History